跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BMS-936559
首页
药物
BMS-936559
BMS-936559
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CARRIER-PD-L1 BINDING AGENT COMPOSITIONS FOR TREATING CANCERS
申请人: MAYO FOUND MEDICAL EDUCATION & RES
优先权: 2016
EP
2 件公开
Compositions comprising chemotherapeutic agents and checkpoint inhibitors and methods of use
申请人: UNIV NORTH CAROLINA STATE
优先权: 2017
CN
US
2 件公开
Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
申请人: KOVARIK JOSEPH E
优先权: 2020
US
Method for treating an individual suffering from a chronic infectious disease and cancer
申请人: KOVARIK JOSEPH E
优先权: 2021
US
2 件公开
Method for treating an individual suffering from bladder cancer
申请人: SEED HEALTH INC
优先权: 2022
US
Method for treating individuals having cancer and who are receiving cancer immunotherapy
申请人: SEED HEALTH INC
优先权: 2022
US
药物
反馈